Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:857-864
Published online before print February 2, 2009, doi: 10.1161/CIRCULATIONAHA.107.755769
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
119/6/857    most recent
CIRCULATIONAHA.107.755769v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersen, M. R.
Right arrow Articles by Stender, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersen, M. R.
Right arrow Articles by Stender, S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Quitting Smoking
Related Collections
Right arrow Lipids
Right arrow Risk Factors
Right arrow Endothelium/vascular type/nitric oxide
Right arrowRelated Article

(Circulation. 2009;119:857-864.)
© 2009 American Heart Association, Inc.


Pediatric Cardiology

Smoking Cessation Early in Pregnancy and Birth Weight, Length, Head Circumference, and Endothelial Nitric Oxide Synthase Activity in Umbilical and Chorionic Vessels

An Observational Study of Healthy Singleton Pregnancies

Malene R. Andersen, MSc, PhD; Ulf Simonsen, MD, PhD; Niels Uldbjerg, MD, PhD; Christian Aalkjær, MD, PhD; Steen Stender, MD, PhD

From the Department of Clinical Biochemistry, Gentofte University Hospital, Hellerup (M.R.A., S.S.); Department of Obstetrics and Gynecology, Aarhus University Hospital, Skejby (M.R.A., N.U.); and Institutes of Pharmacology (U.S.) and Physiology and Biophysics (C.A.), Aarhus University, Aarhus, Denmark.

Correspondence to Malene R. Andersen, Department of Clinical Biochemistry, Gentofte University Hospital, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark. E-mail mardan01{at}geh.regionh.dk

Received November 26, 2007; accepted November 24, 2008.

Background— Reduced production of the vasodilator nitric oxide (NO) in fetal vessels in pregnant smokers may lower the blood flow to the fetus and result in lower birth weight, length, and head circumference. The present study measured endothelial NO synthase (eNOS) activity in fetal umbilical and chorionic vessels from nonsmokers, smokers, and ex-smokers and related the findings to the fetal outcome.

Methods and Results— Of 266 healthy, singleton pregnancies, 182 women were nonsmokers, 43 were smokers, and 41 stopped smoking early in pregnancy. eNOS activity and concentration were quantified in endothelial cells of the fetal vessels. Cotinine, lipid profiles, estradiol, L-arginine, and dimethylarginines that may affect NO production were determined in maternal and fetal blood. Serum cotinine verified self-reported smoking. Newborns of smokers had a lower weight (P≤0.001) and a smaller head circumference (P≤0.041) and were shorter (P≤0.001) than newborns of nonsmokers and ex-smokers. eNOS activity in umbilical veins of smokers was 36% lower (P<0.001), eNOS concentration was 47% lower (P<0.001), and the fetal plasma level of high-density lipoprotein was 18% lower (P<0.001) than those of nonsmokers, whereas the same levels were found in umbilical veins from ex-smokers and nonsmokers. The same patterns in eNOS activity and concentration were found in umbilical arteries and chorionic vessels. Fetal plasma levels of estradiol, L-arginine, dimethylarginines, total cholesterol, and triglycerides were similar for nonsmokers, smokers, and ex-smokers.

Conclusions— The findings suggest that maternal smoking reduces eNOS activity in the fetal vascular bed, contributing to retarded fetal growth caused by the reduction of vasodilatory capacity, and suggest that smoking cessation early in pregnancy prevents these effects in newborns.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 119: 765-767. [Extract] [Full Text]